152 related articles for article (PubMed ID: 11042699)
1. SPI-1 transforming properties depend upon specifically activated forms of the EPOR.
Pereira R; Raingeaud J; Pironin M; Ghysdael J; Quang CT
Oncogene; 2000 Oct; 19(44):5106-10. PubMed ID: 11042699
[TBL] [Abstract][Full Text] [Related]
2. Cooperation of Spi-1/PU.1 with an activated erythropoietin receptor inhibits apoptosis and Epo-dependent differentiation in primary erythroblasts and induces their Kit ligand-dependent proliferation.
Quang CT; Wessely O; Pironin M; Beug H; Ghysdael J
EMBO J; 1997 Sep; 16(18):5639-53. PubMed ID: 9312023
[TBL] [Abstract][Full Text] [Related]
3. FLI-1 inhibits differentiation and induces proliferation of primary erythroblasts.
Pereira R; Quang CT; Lesault I; Dolznig H; Beug H; Ghysdael J
Oncogene; 1999 Feb; 18(8):1597-608. PubMed ID: 10102630
[TBL] [Abstract][Full Text] [Related]
4. The interaction of the erythropoietin receptor and gp55.
D'Andrea AD
Cancer Surv; 1992; 15():19-36. PubMed ID: 1451111
[TBL] [Abstract][Full Text] [Related]
5. Activation of cell growth by binding of Friend spleen focus-forming virus gp55 glycoprotein to the erythropoietin receptor.
Li JP; D'Andrea AD; Lodish HF; Baltimore D
Nature; 1990 Feb; 343(6260):762-4. PubMed ID: 2154701
[TBL] [Abstract][Full Text] [Related]
6. Role of gp55 in restoring the sensitivity of Friend murine erythroleukemia cells to erythropoietin by exposure to dimethyl sulfoxide.
Lin TS; Ishiguro K; Sartorelli AC
Oncol Res; 1998; 10(4):175-84. PubMed ID: 9778688
[TBL] [Abstract][Full Text] [Related]
7. Endogenous p53 regulation and function in early stage Friend virus-induced tumor progression differs from that following DNA damage.
Kelley LL; Hicks GG; Hsieh FF; Prasher JM; Green WF; Miller MD; Eide EJ; Ruley HE
Oncogene; 1998 Sep; 17(9):1119-30. PubMed ID: 9764822
[TBL] [Abstract][Full Text] [Related]
8. Spi-1 transgenic mice develop a clonal erythroleukemia which does not depend on p53 mutation.
Barnache S; Wendling F; Lacombe C; Denis N; Titeux M; Vainchenker W; Moreau-Gachelin F
Oncogene; 1998 Jun; 16(23):2989-95. PubMed ID: 9662331
[TBL] [Abstract][Full Text] [Related]
9. The Fli-1 proto-oncogene, involved in erythroleukemia and Ewing's sarcoma, encodes a transcriptional activator with DNA-binding specificities distinct from other Ets family members.
Zhang L; Lemarchandel V; Romeo PH; Ben-David Y; Greer P; Bernstein A
Oncogene; 1993 Jun; 8(6):1621-30. PubMed ID: 8502483
[TBL] [Abstract][Full Text] [Related]
10. Mutation of the Lyn tyrosine kinase delays the progression of Friend virus induced erythroleukemia without affecting susceptibility.
Subramanian A; Hegde S; Correll PH; Paulson RF
Leuk Res; 2006 Sep; 30(9):1141-9. PubMed ID: 16527351
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Friend cells proliferation by spi-1 antisense oligodeoxynucleotides.
Delgado MD; Hallier M; Meneceur P; Tavitian A; Moreau-Gachelin F
Oncogene; 1994 Jun; 9(6):1723-7. PubMed ID: 8183568
[TBL] [Abstract][Full Text] [Related]
12. Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.
Afrikanova I; Yeh E; Bartos D; Watowich SS; Longmore GD
Oncogene; 2002 Feb; 21(8):1272-84. PubMed ID: 11850847
[TBL] [Abstract][Full Text] [Related]
13. Activation of the JAK1-STAT5 pathway by binding of the Friend virus gp55 glycoprotein to the erythropoietin receptor.
Yamamura Y; Senda H; Noda M; Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():432-4. PubMed ID: 9209415
[TBL] [Abstract][Full Text] [Related]
14. Loss of p53 in F-MuLV induced-erythroleukemias accelerates the acquisition of mutational events that confers immortality and growth factor independence.
Wong KS; Li YJ; Howard J; Ben-David Y
Oncogene; 1999 Sep; 18(40):5525-34. PubMed ID: 10523829
[TBL] [Abstract][Full Text] [Related]
15. Epo regulates erythroid proliferation and differentiation through distinct signaling pathways: implication for erythropoiesis and Friend virus-induced erythroleukemia.
Zochodne B; Truong AH; Stetler K; Higgins RR; Howard J; Dumont D; Berger SA; Ben-David Y
Oncogene; 2000 May; 19(19):2296-304. PubMed ID: 10822380
[TBL] [Abstract][Full Text] [Related]
16. Erythropoietin receptor binds to Friend virus gp55 through other membrane components.
Kishi A; Chiba T; Sugiyama M; Machide M; Nagata Y; Amanuma H; Taira H; Katsumata T; Todokoro K
Biochem Biophys Res Commun; 1993 May; 192(3):1131-8. PubMed ID: 8507186
[TBL] [Abstract][Full Text] [Related]
17. Mutational analysis of the structure-function relationship of the leukemogenic membrane glycoprotein (GP55) of Friend spleen focus-forming virus (F-SFFV).
Amanuma H; Yugawa T; Watanabe N; Ikawa Y
Leukemia; 1997 Apr; 11 Suppl 3():160-1. PubMed ID: 9209329
[TBL] [Abstract][Full Text] [Related]
18. Erythroleukaemia induction by the Friend spleen focus-forming virus.
Ruscetti SK
Baillieres Clin Haematol; 1995 Mar; 8(1):225-47. PubMed ID: 7663048
[TBL] [Abstract][Full Text] [Related]
19. Friend spleen focus-forming virus transforms rodent fibroblasts in cooperation with a short form of the receptor tyrosine kinase Stk.
Nishigaki K; Hanson C; Jelacic T; Thompson D; Ruscetti S
Proc Natl Acad Sci U S A; 2005 Oct; 102(43):15488-93. PubMed ID: 16223879
[TBL] [Abstract][Full Text] [Related]
20. Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation.
Rimmelé P; Kosmider O; Mayeux P; Moreau-Gachelin F; Guillouf C
Blood; 2007 Apr; 109(7):3007-14. PubMed ID: 17132716
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
